"Is this safety issue more likely to happen in the USA? The FDA approves drugs more rapidly than the EMA or Health Canada. The median review time for the FDA is a 3 months shorter than the other regulatory authorities (<9 months for the FDA, compared to ~12 months at the EMA and Health Canada). Are American citizens better off than Europeans or Canadians with regard to new drug approvals? Or is the FDA exposing MSers to greater risks? Choose your fire?"
Read whole article: Elie Dolgin. FDA outpaces its global peers at drug reviews. Nature Med. 16 May 2012.